moxifloxacin has been researched along with betrixaban in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (betrixaban) | Trials (betrixaban) | Recent Studies (post-2010) (betrixaban) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 95 | 19 | 82 |
| Protein | Taxonomy | moxifloxacin (IC50) | betrixaban (IC50) |
|---|---|---|---|
| Prothrombin | Homo sapiens (human) | 0.018 | |
| Coagulation factor X | Homo sapiens (human) | 0.0035 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 8.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gretler, DD; Hollenbach, SJ; Lambing, JL; Morganroth, J; Sinha, U | 1 |
1 trial(s) available for moxifloxacin and betrixaban
| Article | Year |
|---|---|
Absence of QTc prolongation with betrixaban: a randomized, double-blind, placebo- and positive-controlled thorough ECG study.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anticoagulants; Aza Compounds; Benzamides; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Pyridines; Quinolines; Young Adult | 2013 |